NDC 43547-023 – Quetiapine
Quetiapine 400 mg/1 · Tablet, Extended Release · Oral
Product NDC43547-023
Product details
- Brand name
- Quetiapine
- Generic name
- Quetiapine
- Labeler
- Solco Healthcare U.S., LLC
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA208781
- Marketed since
- April 1, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Atypical Antipsychotic
Active ingredients
- Quetiapine 400 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 43547-023-06 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (43547-023-06) | Apr 1, 2022 |
| 43547-023-50 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43547-023-50) | Apr 1, 2022 |
Other Quetiapine products
- 68001-598 Quetiapine Fumarate 50 mg/1 · Tablet, Extended Release · BluePoint Laboratories
- 68001-602 Quetiapine Fumarate 400 mg/1 · Tablet, Extended Release · BluePoint Laboratories
- 68001-601 Quetiapine Fumarate 300 mg/1 · Tablet, Extended Release · BluePoint Laboratories
- 68001-599 Quetiapine Fumarate 150 mg/1 · Tablet, Extended Release · BluePoint Laboratories
- 68001-600 Quetiapine Fumarate 200 mg/1 · Tablet, Extended Release · BluePoint Laboratories
- 71335-2641 Quetiapine Fumarate 400 mg/1 · Tablet, Extended Release · Bryant Ranch Prepack
- 63629-5944 Quetiapine Fumarate 400 mg/1 · Tablet, Extended Release · Bryant Ranch Prepack
- 67046-1623 Quetiapine Fumarate 200 mg/1 · Tablet, Extended Release · Coupler LLC
- 33342-137 Quetiapine Fumarate 400 mg/1 · Tablet, Extended Release · Macleods Pharmaceuticals Limited
- 33342-136 Quetiapine Fumarate 300 mg/1 · Tablet, Extended Release · Macleods Pharmaceuticals Limited
- 33342-135 Quetiapine Fumarate 200 mg/1 · Tablet, Extended Release · Macleods Pharmaceuticals Limited
- 33342-134 Quetiapine Fumarate 150 mg/1 · Tablet, Extended Release · Macleods Pharmaceuticals Limited